The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer

Oxaliplatin (OXA) resistance is the major obstacle to the anticancer effects of chemotherapy in colorectal cancer (CRC) patients. MicroRNAs (miRNAs) play an important role in the chemoresistance of various tumors. Our objective is to clarify the underlying mechanism of miRNAs in chemoresistance and provide a potential strategy to improve the response of CRC patients to chemotherapeutics. Methods: MiRNA microarray and Real-time PCR were performed to compare changes in miRNA expression between oxaliplatin-resistant and the parental cells. CCK8, apoptosis assay, immunofluorescence and xenograft studies were used to elucidate the impact of miR-27b-3p on regulating chemoresistance. Luciferase reporter assay and western blot were carried to assess the regulatory role of miR-27b-3p in ATG10 expression. The effects of miR-27b-3p and ATG10 on autophagy were investigated by GFP-LC3 fluorescence microscopy, transmission electron microscopy, and western blot. ChIP assay and luciferase assay were performed to test the c-Myc's occupancy on the miR-27B promoter. Results: We observed that miR-27b-3p expression was significantly downregulated in oxaliplatin-resistant cell lines (SW480-OxR and HCT116-OxR) compared to the corresponding parental cell lines and that miR-27b-3p expression was positively correlated with disease-free survival (DFS) time in colorectal cancer patients. MiR-27b-3p could sensitize colorectal cancer cells to oxaliplatin in vitro and in vivo. Under oxaliplatin treatment, chemoresistant cells showed a higher autophagy level than parental cells. Moreover, we also identified that miR-27b-3p inhibited the expression of ATG10 at the posttranscriptional level, thus inhibiting autophagy. Further study demonstrated that c-Myc can inhibit the expression of miR-27b-3p via binding to the promoter region of miR-27B gene. Conclusions: Our study identifies a novel c-Myc/miR-27b-3p/ATG10 signaling pathway that regulates colorectal cancer chemoresistance. These results suggest that miR-27b-3p is not only a potential indicator for evaluating efficiency of chemotherapy, but also a valuable therapeutic target for CRC, especially for patients with chemoresistance.

[1]  A. Pennetti,et al.  MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer , 2019, Cell Death & Disease.

[2]  W. Xiong,et al.  The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo–TAZ pathway , 2019, Oncogene.

[3]  Yan Ding,et al.  CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer , 2019, Molecular Cancer.

[4]  Zhaohui Tang,et al.  Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy , 2019, Molecular Cancer.

[5]  L. Du,et al.  Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer , 2019, Molecular Cancer.

[6]  C. James,et al.  MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy , 2019, Autophagy.

[7]  Gebert Lfr,et al.  Regulation of microRNA function in animals , 2019 .

[8]  Jacqueline A. Hall,et al.  A framework for the development of effective anti-metastatic agents , 2018, Nature Reviews Clinical Oncology.

[9]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[10]  Weiqun Peng,et al.  miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer , 2018, Oncogene.

[11]  I. MacRae,et al.  Regulation of microRNA function in animals , 2018, Nature Reviews Molecular Cell Biology.

[12]  Jianda Dong,et al.  miR‐27b‐3p is Involved in Doxorubicin Resistance of Human Anaplastic Thyroid Cancer Cells via Targeting Peroxisome Proliferator‐Activated Receptor Gamma , 2018, Basic & clinical pharmacology & toxicology.

[13]  C. Ivan,et al.  Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer , 2018, Molecular Cancer.

[14]  Xi Chen,et al.  MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway , 2018, Cell Death & Disease.

[15]  C. Chiang,et al.  Graphene oxide sensitizes cancer cells to chemotherapeutics by inducing early autophagy events, promoting nuclear trafficking and necrosis , 2018, Theranostics.

[16]  Dajun Yang,et al.  XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells , 2018, Theranostics.

[17]  W. Fan,et al.  miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells , 2018, Cell Death & Disease.

[18]  A. Thorburn,et al.  Targeting autophagy in cancer , 2017, Nature Reviews Cancer.

[19]  Fangfang Guo,et al.  Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy , 2017, Cell.

[20]  Ziheng Zhuang,et al.  FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer , 2017, Molecular oncology.

[21]  A. Jemal,et al.  Colorectal cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[22]  E. Papaleo,et al.  MIR7–3HG, a MYC-dependent modulator of cell proliferation, inhibits autophagy by a regulatory loop involving AMBRA1 , 2017, Autophagy.

[23]  Christina Backes,et al.  miRPathDB: a new dictionary on microRNAs and target pathways , 2016, Nucleic Acids Res..

[24]  Zeming Liu,et al.  A potential role for the Hippo pathway protein, YAP, in controlling proliferation, cell cycle progression, and autophagy in BCPAP and KI thyroid papillary carcinoma cells. , 2017, American journal of translational research.

[25]  W. Guan,et al.  miR-27b inhibits gastric cancer metastasis by targeting NR2F2 , 2016, Protein & Cell.

[26]  Xiaoyan Chen,et al.  Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[27]  Hongbing Shen,et al.  Role of ATG10 expression quantitative trait loci in non‐small cell lung cancer survival , 2016, International journal of cancer.

[28]  P. Nelson,et al.  miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1) , 2016, Molecular Neurodegeneration.

[29]  Ming Qin,et al.  Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin , 2016, Autophagy.

[30]  M. Okada,et al.  MicroRNA‐27b suppresses tumor progression by regulating ARFGEF1 and focal adhesion signaling , 2015, Cancer science.

[31]  F. Loupakis,et al.  First-line chemotherapy for mCRC—a review and evidence-based algorithm , 2015, Nature Reviews Clinical Oncology.

[32]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[33]  L. Larsson,et al.  Targeting MYC Translation in Colorectal Cancer. , 2015, Cancer discovery.

[34]  K. Zen,et al.  The Transcription Factor C-Myc Suppresses MiR-23b and MiR-27b Transcription during Fetal Distress and Increases the Sensitivity of Neurons to Hypoxia-Induced Apoptosis , 2015, PloS one.

[35]  R. Goldberg,et al.  Recent therapeutic advances in the treatment of colorectal cancer. , 2015, Annual review of medicine.

[36]  Yuan Yin,et al.  miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A , 2014, Clinical Cancer Research.

[37]  D. Klionsky,et al.  Structures of Atg7-Atg3 and Atg7-Atg10 reveal noncanonical mechanisms of E2 recruitment by the autophagy E1 , 2013, Autophagy.

[38]  Seung-Woo Hong,et al.  Increased Expression of ATG10 in Colorectal Cancer Is Associated with Lymphovascular Invasion and Lymph Node Metastasis , 2012, PloS one.

[39]  K. Struhl,et al.  MiR-27b targets PPARγ to inhibit growth, tumor progression, and the inflammatory response in neuroblastoma cells , 2011, Oncogene.

[40]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[41]  L. Howells,et al.  Curcumin ameliorates oxaliplatin‐induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo , 2011, International journal of cancer.

[42]  D. Cunningham,et al.  First-line treatment of advanced colorectal cancer , 2011, The Lancet.

[43]  Jun S. Song,et al.  Chromatin structure analyses identify miRNA promoters , 2008 .

[44]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[45]  Tsung-Cheng Chang,et al.  Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.

[46]  Yvonne Tay,et al.  A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes , 2006, Cell.

[47]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.